Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
Share Market News
5 things to watch on the ASX 200 on Thursday
Dividend Investing
The Cochlear dividend is being paid today. Here's what you need to know
Healthcare Shares
The Cochlear share price has shaved 13% from its all-time high. Is now the time to pounce?
Healthcare Shares
ASX 200 healthcare shares were chronically ill last quarter. Take a look
Healthcare Shares
What's the outlook for the Cochlear share price in April?
Broker Notes
3 more of the 'best' ASX 200 shares to buy this month: Morgans
Dividend Investing
Why is the Cochlear (ASX:COH) share price sliding today?
Healthcare Shares
3 ASX healthcare shares rated as buys by a leading broker
Dividend Investing
Keen to bank the Cochlear (ASX:COH) dividend? Here's what you need to know
Healthcare Shares
The Cochlear (ASX:COH) share price has bounced back from the pandemic. Are there more gains to come?
Broker Notes
Cheap ASX share better than Woolworths (ASX:WOW)– and it pays dividends
Broker Notes
The next ASX share ready to join the 20-bagger club: expert
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
